J. Wilson

发表

Adenovirus-mediated gene transfer to liver.

James M. Wilson, J. Wilson, 1995, Advanced drug delivery reviews.

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

James M. Wilson, J. Wilson, K. Molnar-Kimber, 1998, Human gene therapy.

Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primates.

J. Wilson, D. Sterman, A. Elshami, 1996, Human gene therapy.

Cell Transplantation in Liver-Directed Gene Therapy

J. Wilson, S. Raper, S. Raper, 1993, Cell transplantation.

Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats.

J. Wilson, C. Wu, Catherine H. Wu, 1991, The Journal of biological chemistry.

Cathelicidins - a family of multifunctional antimicrobial peptides

James M. Wilson, R. Bals, J. Wilson, 2003, Cellular and Molecular Life Sciences CMLS.

Animal models of human disease for gene therapy.

J. Wilson, James M. Wilson, 1996, The Journal of clinical investigation.

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.

V. Bafna, R. Bals, J. Wilson, 1998, The Journal of clinical investigation.

Human hypoxanthine-guanine phosphoribosyltransferase. Detection of a mutant allele by restriction endonuclease analysis.

R. Nussbaum, C. Caskey, J. Wilson, 1983, The Journal of clinical investigation.

Membrane domains of intestinal epithelial cells: distribution of Na+,K+- ATPase and the membrane skeleton in adult rat intestine during fetal development and after epithelial isolation

J. Wilson, M. Neutra, J. Mack, 1989, The Journal of cell biology.

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

L. Turka, J. Wilson, Y. Chen, 1997, The Journal of clinical investigation.

HGPRT-deficiency--the molecular basis of the clinical syndromes.

J. Wilson, J. Searle, W. N. Kelley, 1986, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin.

Molecular genetics of the HPRT-deficiency syndromes.

J. Wilson, W. N. Kelley, W. Kelley, 1984, Hospital Practice.

Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza

G. Wong, G. Kobinger, James M. Wilson, 2013, Science Translational Medicine.

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes.

R. Balice-Gordon, H. Sweeney, J. Wilson, 1996, Human gene therapy.

Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR.

F. Collins, J. Wilson, J. Engelhardt, 1993, Human molecular genetics.

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

M. Weitzman, R. DeMatteo, James M. Wilson, 1996, Journal of virology.

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.

S. Fawell, J. Wilson, G. Gao, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

J. Wilson, G. Gao, J. Tazelaar, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

J. Wilson, G. Gao, N. Chirmule, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

James M. Wilson, J. Wilson, K. Molnar-Kimber, 1998, Human gene therapy.

A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence

J. Wilson, J. Linden, J. Rieger, 2009, Mucosal Immunology.

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.

R. Bals, J. Wilson, M. Zasloff, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice.

S. Fawell, J. Wilson, J. Barsoum, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Targeted delivery of antisense oligonucleotides by molecular conjugates

F. Askari, J. Wilson, B. Bunnell, 1992, Somatic cell and molecular genetics.

Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

J. Wilson, S. E. Haecker, Y. Yang, 1996, Human molecular genetics.

Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.

J. Wilson, N. Chirmule, Y. Chen, 1999, Human gene therapy.

Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions.

J. Wilson, M. Croyle, Q. Yu, 2000, Human gene therapy.

Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.

J. Wilson, L. G. Johnson, R. Boucher, 1995, The Journal of clinical investigation.

Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer.

J. Krauss, J. Wilson, D. Anderson, 1990, Science.

Methods of gene delivery.

James M. Wilson, J. Wilson, N. Wivel, 1998, Hematology/oncology clinics of North America.

Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic colorectal carcinoma.

D. Fraker, F. Spitz, J. Wilson, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Lentiviral vectors for gene therapy of cystic fibrosis.

J. Wilson, J. S. Yang, M. Goldman, 1997, Human gene therapy.

Reconstitution of tracheal grafts with a genetically modified epithelium.

J. Wilson, J. Engelhardt, E. Allen, 1991, Proceedings of the National Academy of Sciences of the United States of America.

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

Z. Xiang, H. Ertl, J. Wilson, 1996, Virology.

Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.

P. Daddona, B. Mitchell, J. Wilson, 1979, The Journal of clinical investigation.

Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response.

W. Dougall, J. Wilson, H. Nick, 1990, The Journal of biological chemistry.

Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.

James M. Wilson, J. Wilson, G. Gao, 2001, Cancer research.

Targeted retroviral gene transfer into the rat biliary tract

James M. Wilson, J. Wilson, S. Raper, 1996, Somatic cell and molecular genetics.

Pulmonary delivery of adenovirus vector formulated with dexamethasone–spermine facilitates homologous vector re-administration

S. Diamond, J. Wilson, M. Limberis, 2007, Gene Therapy.

Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration.

E. Furth, J. Wilson, S. Raper, 1999, Human gene therapy.

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

Z. Xiang, H. Ertl, J. Wilson, 2003, Journal of Virology.

Antihyperglycemic action of guanidinoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL6Job/ob mice and increases glucose disappearance in rhesus monkeys.

J. Wilson, M. Meglasson, D. D. Robinson, 1993, The Journal of pharmacology and experimental therapeutics.

Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.

D. Hackney, K. Judy, J. Wilson, 1997, Human gene therapy.

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.

Z. Xiang, H. Ertl, J. Wilson, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo.

James M. Wilson, J. Wilson, C. Wu, 1989, The Journal of biological chemistry.

Developing adenoviral-mediated in vivo gene therapy for ornithine transcarbamylase deficiency

M. Yudkoff, J. Wilson, S. Raper, 1998, Journal of Inherited Metabolic Disease.

Somatic gene transfer in the development of an animal model for primary hyperparathyroidism.

R. Mulligan, A. Rosenberg, H. Kronenberg, 1992, Endocrinology.

Altered expression of caveolin-1 and increased cholesterol in detergent insoluble membrane fractions from liver in mice with Niemann-Pick disease type C.

R. Erickson, J. Wilson, R. Heidenreich, 1997, Biochimica et biophysica acta.

Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

H. Ertl, James M. Wilson, J. Wilson, 1996, Gene therapy.

Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

James M. Wilson, J. Wilson, Y. Yang, 1995, Journal of immunology.

The formation and toxicity of catechol metabolites of acetaminophen in mice.

J. Wilson, S. Nelson, J. Slattery, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites

J. Inostroza, J. Wilson, H. Zhang, 1995, Molecular and cellular biology.

The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment.

J. Wilson, J. Cohn, J. M. Wilson, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.

J. Pilewski, H. Hwang, W. Smythe, 1994, The Annals of thoracic surgery.

Implantation of vascular grafts lined with genetically modified endothelial cells.

P. Libby, A. Callow, R. Mulligan, 1989, Science.

Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments.

R. Erickson, J. Wilson, R. Heidenreich, 2000, Journal of lipid research.

Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy

J. Wilson, G. Gao, Y. Yang, 1996, Journal of virology.

Human Immunodeficiency Virus Type 1-Specific Immune Responses in Primates upon Sequential Immunization with Adenoviral Vaccine Carriers of Human and Simian Serotypes

Z. Xiang, H. Ertl, J. Wilson, 2004, Journal of Virology.

The Glucokinase Glucose Sensor in Human Pancreatic Islet Tissue

D. Finegold, J. Wilson, F. Matschinsky, 1986, Diabetes.

Radiometric oil well assay for glucokinase in microscopic structures.

J. Wilson, F. Matschinsky, F. Bedoya, 1985, Analytical biochemistry.

Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits.

N. Davidson, James M. Wilson, J. Wilson, 1996, Human gene therapy.

Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor.

D. Rader, J. Wilson, G. Gao, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Presence of insulin-like growth factors and their binding proteins in rat milk.

J. Wilson, O. Koldovský, A. Philipps, 1991, Advances in experimental medicine and biology.

Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells.

R. Mulligan, O. Danos, J. Wilson, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Human hypoxanthine-guanine phosphoribosyltransferase: studies of the normal and five mutant forms of the enzyme.

J. Wilson, W. N. Kelley, W. Kelley, 1983, Transactions of the American Clinical and Climatological Association.

Immune responses to adenovirus and adeno-associated virus in humans

K. Propert, James M. Wilson, J. Wilson, 1999, Gene Therapy.

Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts.

J. Wilson, D. Muller, S. Chen, 1994, Circulation.

Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

D. Rader, B. Clark, J. Wilson, 1996, Annals of surgery.

Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway

J. Wilson, M. Goldman, J. Wilson, 1995, Journal of virology.

Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.

J. Wilson, J. Baker, N. Chowdhury, 1991, Science.

Cytoplasmic Signals Mediate Apical Early Endosomal Targeting of Endotubin in MDCK Cells

J. Wilson, K. E. Gokay, R. S. Young, 2001, Traffic.

Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

S. Lippard, K. Yarema, J. Essigmann, 1994, Journal of molecular biology.

Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model.

R. Bals, J. Wilson, D. Weiner, 1999, The Journal of clinical investigation.

Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.

J. Wilson, G. Gao, N. Chirmule, 1999, Journal of immunology.

Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.

J. Mendell, J. Wilson, H. Stedman, 2000, Human gene therapy.

Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.

B. Davidson, James M. Wilson, H. Hwang, 1994, Cancer research.

A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis.

K. Propert, J. Wilson, N. Chirmule, 1999, Human gene therapy.

Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues

R. Flavell, J. Wilson, R. Schilz, 1996, Journal of virology.

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

James M. Wilson, J. Wilson, L. Litzky, 1994, Human gene therapy.

Biogenesis of the apical endosome-lysosome complex during differentiation of absorptive epithelial cells in rat ileum.

J. Wilson, M. Neutra, J. A. Whitney, 1991, Journal of cell science.

Relationships between energy level and insulin secretion in isolated rat islets of Langerhans. Manipulation of [ATP]/[ADP][Pi] by 2-deoxy-D-glucose.

M. Erecińska, J. Wilson, D. Nelson, 1992, Biochemical pharmacology.

Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer.

James M. Wilson, J. Wilson, M. Grossman, 1993, The American journal of cardiology.

Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women.

R. Baumgartner, P. Garry, J. Wilson, 2001, Clinical biochemistry.

Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells.

J. Wilson, R. Fram, N. Robichaud, 1987, Cancer research.

Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.

R. Mulligan, A. Epstein, J. Wilson, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Molecular genetics of hypoxanthine-guanine phosphoribosyltransferase deficiency in man.

J. Wilson, W. N. Kelley, W. Kelley, 1985, Archives of internal medicine.

Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.

J. Moffett, J. Wilson, N. Chirmule, 1999, Human gene therapy.

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

J. Wilson, N. Chirmule, J. Tazelaar, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome.

J. Wilson, K. Fisher, J. Burda, 1996, Human gene therapy.

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study.

J. Wilson, J. Engelhardt, M. Grossman, 1993, Human gene therapy.

Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.

H. Sweeney, James M. Wilson, J. Wilson, 2001, Human gene therapy.

A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes.

J. Wilson, C. Wu, Catherine H. Wu, 1992, The Journal of biological chemistry.

Polarity of endogenous and exogenous glycosyl-phosphatidylinositol-anchored membrane proteins in Madin-Darby canine kidney cells.

J. Wilson, N. Fasel, J. Kraehenbuhl, 1990, Journal of cell science.

ICAM-1 expression on bronchial epithelium after recombinant adenovirus infection.

J. Pilewski, J. Wilson, S. Albelda, 1995, American journal of respiratory cell and molecular biology.

Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers

M. Weitzman, James M. Wilson, J. Wilson, 1996, Journal of virology.

Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.

R. Mulligan, J. Wilson, D. Jefferson, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits.

J. Wilson, C. Wu, Catherine H. Wu, 1992, The Journal of biological chemistry.

Efficient induction of protective anti-malaria immunity by recombinant adenovirus.

James M. Wilson, J. Wilson, M. Tsuji, 1998, Vaccine.

An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer.

J. Wilson, S. Raper, J. Engelhardt, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Retrovirus-mediated transduction of adult hepatocytes.

R. Mulligan, James M. Wilson, P. Novikoff, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Plasma disappearance of rabbit α2 HS-glycoprotein and its uptake by bone tissue

J. Wilson, J. Triffitt, B. Ashton, 1978, Calcified Tissue Research.

Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.

James M. Wilson, J. Wilson, M. Tsuji, 1997, Journal of immunology.

Transport of horseradish peroxidase across monkey trophoblastic epithelium in coated and uncoated vesicles

J. Wilson, Jean M. Wilson, B. King, 1985, The Anatomical record.

Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naïve and pre-immunized mice

James M. Wilson, J. Wilson, G. Gao, 2005, Gene Therapy.

Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo.

J. Wilson, M. Croyle, X. Cheng, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study.

J. Wilson, L. Litzky, J. Engelhardt, 1995, Human gene therapy.

Adenovirus-mediated gene transfer to human bronchial submucosal glands using xenografts.

J. Bavaria, J. Pilewski, J. Wilson, 1995, The American journal of physiology.

Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis.

J. Wilson, Q. Su, M. Goldman, 1996, Gene therapy.

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs

James M. Wilson, J. Wilson, Y. Yang, 1996, Journal of virology.

Influence of Chronic Cocaine on Monoamine Neurotransmitters in Human Brain and Animal Model: Preliminary Observations

J. Nobrega, S. Kish, K. Shannak, 1992, Annals of the New York Academy of Sciences.

A fine structural and cytochemical study of the rhesus monkey yolk sac: Endoderm and mesothelium

J. Wilson, Jean M. Wilson, B. King, 1983, The Anatomical record.

Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.

S. Kish, H. Niznik, Z. Pristupa, 1994, Molecular pharmacology.

Selective repopulation of normal mouse liver by hepatocytes transduced in vivo with recombinant adeno-associated virus.

J. Wilson, J. Tazelaar, S. Chen, 2001, Human gene therapy.

Provocative gene therapy strategy for the treatment of hepatocellular carcinoma

F. Askari, J. Wilson, James Wilson, 1992, Hepatology.

Gene therapy of hypercholesterolemic disorders.

J. Wilson, K. Kozarsky, 1995, Trends in cardiovascular medicine.

Human hypoxanthine-guanine phosphoribosyltransferase. Tryptic peptides and post-translational modification of the erythrocyte enzyme.

J. Wilson, W. N. Kelley, L. Landa, 1982, The Journal of biological chemistry.

Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.

A. Alavi, D. Hackney, K. Propert, 2001, Human gene therapy.

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

J. Wilson, K. Jooss, Y. Yang, 1996, Human gene therapy.

Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver.

J. Wilson, Y. Yang, Yiping Yang, 1996, Gene therapy.

An in vivo animal model of gene therapy for leukocyte adhesion deficiency.

J. Krauss, K. Weber, J. Wilson, 1991, The Journal of clinical investigation.

Adenoviral-mediated gene transfer to rabbit synovium in vivo.

B. Davidson, J. Wilson, B. Roessler, 1993, The Journal of clinical investigation.

Gene therapy for human liver disease.

J. Wilson, S. Raper, 1995, Progress in liver diseases.

Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.

K. Kurachi, E. Nabel, J. Wilson, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Role of CFTR in lysosome acidification.

R. V. Van Dyke, J. Wilson, K. Root, 1992, Biochemical and biophysical research communications.

Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector.

H. Ertl, J. Wilson, G. Gao, 2004, Vaccine.

bcl-2 gene therapy exacerbates excitotoxicity.

J. Bennett, D. Zurakowski, J. Wilson, 1999, Human gene therapy.

Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.

H. Sweeney, J. Wilson, G. Gao, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

A. Alavi, D. Hackney, K. Judy, 1996, Human gene therapy.

Influence of dietary sodium on renin activity and arterial pressure during anesthesia.

W. Strull, J. Wilson, J. Fray, 1976, The American journal of physiology.

Sorting and transepithelial transport of adsorbed protein tracers: Effects of temperature

J. Wilson, Jean M. Wilson, B. King, 1986, The Anatomical record.

Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

M. Tuchman, M. Yudkoff, James M. Wilson, 2000, American journal of medical genetics.

Identification of an endosomal antigen specific to absorptive cells of suckling rat ileum

J. Wilson, M. Neutra, J. A. Whitney, 1987, The Journal of cell biology.

Recombinant adenovirus gene transfer in adults with partial ornithine transcarbamylase deficiency (OTCD).

M. Yudkoff, J. Wilson, S. Raper, 1999, Human gene therapy.

Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.

J. Wilson, G. Gao, S. Raper, 1998, Human gene therapy.

Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme.

P. Daddona, J. Wilson, B. W. Baugher, 1982, The Journal of clinical investigation.

Human adenine phosphoribosyltransferase. Immunochemical quantitation and protein blot analysis of mutant forms of the enzyme.

H. Simmonds, P. Daddona, J. Wilson, 1982, The Journal of biological chemistry.

The effect of perinatal lead administration on the ontogeny of striatal enkephalin levels in the rat.

L. B. Clayton, P. D. Lewis, S. Gardiner, 1984, Toxicology and applied pharmacology.

Hepatocyte Transplantation: Development of New Systems for Liver Repopulation and Gene Therapy

J. Wilson, J. Chowdhury, S. Gupta, 1992, Seminars in liver disease.

Construction of adenoviral vectors

A. Davis, James M. Wilson, J. Wilson, 2001, Molecular biotechnology.

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

E. Furth, J. Wilson, G. Gao, 1998, Human gene therapy.

Adenovirus-mediated gene transfer by perivitelline microinjection of mouse, rat, and cow embryos.

R. Roberts, J. Wilson, M. Larson, 1997, Biology of reproduction.

Analysis of Dezocine in Serum and Urine by High Performance Liquid Chromatography and Pre-Column Derivatizationxs

J. Wilson, E. Smith, R. Cohen, 1994 .

Human gene marker/therapy clinical protocols.

K. Cornetta, J. Roth, R. Crystal, 1996, Human gene therapy.

Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy.

J. Bennett, J. Wilson, S. Reich, 2003, Human gene therapy.

ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients

J. Wilson, Y. Song, J. Woodfolk, 2022, medRxiv.

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.

James M. Wilson, J. Wilson, S. Kung, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Production of recombinant adeno-associated virus.

J. Wilson, G. Gao, N. Wivel, 2000, Advances in virus research.

Low-level lead exposure alters morphine antinociception in neonatal rats.

J. Wilson, C. Winder, I. Kitchen, 1984, Toxicology letters.

Fast atom bombardment-mass spectrometry for bacterial chemotaxonomy: influence of culture age, growth temperature, gaseous environment and extraction technique.

J. Wilson, H. Aluyi, D. Drucker, 1992, The Journal of applied bacteriology.

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

H. Ertl, James M. Wilson, J. Wilson, 1995, Journal of virology.

Pyridine nucleotides and phosphorylation potential of rabbit corneal epithelium and endothelium.

F M Matschinsky, B R Masters, B. Masters, 1989, Investigative ophthalmology & visual science.

Retroviruses: delivery vehicle to the liver.

J. Wilson, M. Grossman, 1993, Current opinion in genetics & development.

Gene therapy: adenovirus vectors.

J. Wilson, K. Kozarsky, J M Wilson, 1993, Current opinion in genetics & development.

Minimal medium recovery of thermally injured Salmonella senftenberg 4969.

J. Wilson, R. Davies, 1976, The Journal of applied bacteriology.

SB 205952, a novel semisynthetic monic acid analog with at least two modes of action

I. Chopra, J. Wilson, B. Oliva, 1995, Antimicrobial agents and chemotherapy.

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

E. Furth, James M. Wilson, Yiping Yang, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of acetaminophen metabolites in urine by high-performance liquid chromatography with UV and amperometric detection.

J. Wilson, S. Nelson, J. Slattery, 1982, Journal of chromatography.

Adenoviruses as gene-delivery vehicles.

J. Wilson, J M Wilson, James M. Wilson, 1996, The New England journal of medicine.

Cells-Diamminedichloroplatinum ( II ) in BE Human Colon Carcinoma cis Characterization of Acquired Resistance to Updated

B. Woda, J. Wilson, N. Robichaud, 2006 .

In vivo measurement of ureagenesis with stable isotopes

M. Yudkoff, J. Wilson, M. Batshaw, 1998, Journal of Inherited Metabolic Disease.

Hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular basis of the clinical syndromes.

J. Wilson, W. N. Kelley, A. Young, 1983, The New England journal of medicine.

Replication-Defective Vector Based on a Chimpanzee Adenovirus

R. M. Burnett, Z. Xiang, H. Ertl, 2001, Journal of Virology.

Expression of the cystic fibrosis gene in adult human lung.

James M. Wilson, J. Wilson, J. Yankaskas, 1994, The Journal of clinical investigation.

MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest.

M. Kunnimalaiyaan, J. Wilson, T. Gamblin, 2014, The Journal of surgical research.

A newly discovered bacterium associated with parthenogenesis and a change in host selection behavior in parasitoid wasps

J. Brown, J. Wilson, Judith K. Brown, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Simultaneous measurement of secondary and tertiary tricyclic antidepressants by GC/MS chemical ionization mass fragmentography.

J. Wilson, V. Raisys, L. Williamson, 1977, Clinical chemistry.

The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans.

D. Griffin, J. Wilson, S. Gitlin, 2014, Human reproduction update.

Co-expression of human Kir3 subunits can yield channels with different functional properties.

H. V. Van Tol, J. Wilson, T. Hébert, 1999, Cellular signalling.

EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts.

R. Parton, J. Wilson, C. Dotti, 2000, Molecular biology of the cell.

Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat.

J C Stanley, W E Burkel, J. Wilson, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Expression of retroviral transduced human CD18 in murine cells: an in vitro model of gene therapy for leukocyte adhesion deficiency.

J. Krauss, J. Wilson, R. Todd, 1991, Human gene therapy.

RETROVIRAL TRANSDUCED HUMAN CD 18 IN MURINE CELLS 223

J. Krauss, J. Wilson, R. Todd, 2022 .

Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium.

G. Boivin, S. Watanabe, J. Wilson, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial of xenografts.

J. Wilson, J. Engelhardt, Y. Yang, 1994, American journal of respiratory cell and molecular biology.

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

G. Kobinger, J. Bennett, James M. Wilson, 2001, Human molecular genetics.

Progress and prospects: gene therapy clinical trials (part 1)

M. Peschanski, E. Chiocca, A. Bachoud-Lévi, 2007, Gene Therapy.

In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses.

J. Wilson, S. Raper, S. Raper, 1994, The Journal of biological chemistry.

Rapid In Vivo Retroviral Gene Transfer into Human Bronchial Epithelia of Xenografts

J. Wilson, J. Yankaskas, J. Engelhardt, 2022 .

Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance.

J. Wilson, R. Frizzell, D. Devor, 1993, Human molecular genetics.

Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.

J. Wilson, J M Wilson, K J Fisher, 1996, Virology.

Prospects for gene therapy of familial hypercholesterolemia.

J. Wilson, J. Chowdhury, 1990, Molecular biology & medicine.

Long-term regulated expression of growth hormone in mice after intramuscular gene transfer.

V. Rivera, J. Wilson, M. Gilman, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.

J. Wilson, J. Engelhardt, B. Doranz, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo.

J. Wilson, G. Gao, N. Chirmule, 2000, Human gene therapy.

Retrovirus-mediated expression of HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes.

F. Askari, J. Wilson, E. Hitomi, 1995, Gene therapy.

Chimpanzee-origin adenovirus vectors as vaccine carriers

H. Ertl, J. Wilson, G. Gao, 2006, Gene Therapy.

Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.

F. Askari, J. Wilson, M. Mao, 1996, Gene therapy.

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

H. Ertl, J. Wilson, J. M. Wilson, 1994, Immunity.

In vivo selection of hepatocytes transduced with adeno-associated viral vectors.

J. Wilson, J. Tazelaar, A. Moscioni, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

James M. Wilson, J. Wilson, G. Gao, 2001, Human gene therapy.

The interaction of a component of bone organic matrix with the mineral phase

J. Wilson, J. Triffitt, B. Ashton, 1976, Calcified Tissue Research.

The small molecular weight, γ-carboxyglutamic acid-containing protein of rabbit bone tissue

J. Wilson, J. Triffitt, J. Wilson, 1984 .

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1

A. Thomas, A. Holder, J. Wilson, 2011, Infection and Immunity.

A. Thomas, A. Holder, James M. Wilson, 2010, Infection and Immunity.

Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A

James M. Wilson, J. Wilson, G. Gao, 2008, Journal of Virology.

Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.

L. Ellis, D. Fraker, F. Spitz, 2001, The Journal of clinical investigation.

Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus.

James M. Wilson, J. Wilson, J. Leiden, 1994, Gene therapy.

Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9

F. Coun, V. Baekelandt, J. Wilson, 2011, Gene Therapy.

Tailoring the AAV vector capsid for gene therapy

J. Wilson, G. Gao, L. Vandenberghe, 2009, Gene Therapy.

Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer.

V. Rivera, P. Zoltick, J. Wilson, 1999, Science.

Muscle‐directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors

J. Wilson, P. Bell, J. Louboutin, 2011, Journal of thrombosis and haemostasis : JTH.

Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy

J. Wilson, Lieven Thorrez, T. VandenDriessche, 2006, Journal of thrombosis and haemostasis : JTH.

When bad gene transfer is good.

J. Wilson, 1996, The Journal of clinical investigation.

MHC-independent presentation of mycobacteria to human gamma delta T cells.

D. Karp, J. Wilson, J. Holoshitz, 1993, International immunology.

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus.

James M. Wilson, P. Zoltick, J. Wilson, 1998, Human gene therapy.

Human hypoxanthine-guanine phosphoribosyltransferase. Complete amino acid sequence of the erythrocyte enzyme.

J. Wilson, W. Mahoney, G. Tarr, 1982, The Journal of biological chemistry.

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.

J. Wilson, G. Gao, M. Chang, 1999, Human gene therapy.

The innate immune system in cystic fibrosis lung disease.

James M. Wilson, R. Bals, J. Wilson, 1999, The Journal of clinical investigation.

Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.

T. Aleman, A. Cideciyan, S. Jacobson, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Adenovirus-mediated gene transfer to human fetal lung ex vivo.

J. Wilson, P. Ballard, M. Schwartz, 1995, The American journal of physiology.

The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo.

J. Wilson, K. Molnar-Kimber, A. Elshami, 1997, Cancer gene therapy.

Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274).

J. Wilson, D. Sterman, L. Kaiser, 1996, Human gene therapy.

Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.

H. V. Van Tol, S. Sanyal, J. Wilson, 1998, European journal of pharmacology.

A possible role for kinase-associated protein phosphatase in the Arabidopsis CLAVATA1 signaling pathway.

E. Meyerowitz, J. Wilson, R. Williams, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial.

J. Wilson, J. Engelhardt, M. Grossman, 1994, Human gene therapy.

T helper cell-independent antibody responses to the transgene product of an e1-deleted adenoviral vaccine require NK1.1 T cells.

Z. Xiang, H. Ertl, J. Wilson, 2003, Virology.

Construction of adenoviral vectors.

A R Davis, N A Wivel, J L Palladino, 2000, Methods in molecular biology.

Gene therapy for cystic fibrosis: challenges and future directions.

J. Wilson, J M Wilson, James M. Wilson, 1995, The Journal of clinical investigation.

Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse

J. Wilson, M. Robinson, X Ye, 2000, Gene Therapy.

Comparison of aneuploidy, pregnancy and live birth rates between day 5 and day 6 blastocysts.

D. Griffin, J. Wilson, S. Gitlin, 2014, Reproductive biomedicine online.

Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage.

M. Marinus, J. Wilson, P. Cusick, 1985, Molecular pharmacology.

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors.

James M. Wilson, J. Wilson, M. Hildinger, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

A possible nucleotide-binding domain in the tertiary fold of phosphoribosyltransferases.

P. Argos, J. Wilson, W. Kelley, 1983, The Journal of biological chemistry.

Human hypoxanthine-guanine phosphoribosyltransferase. Purification and characterization of mutant forms of the enzyme.

J. Wilson, B. W. Baugher, L. Landa, 1981, The Journal of biological chemistry.

Gas chromatography/mass spectrometry of bacterial amines.

J. Wilson, D. Drucker, A. Tavakkol, 1985, Biomedical mass spectrometry.

A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man.

B. Davidson, C. Caskey, J. Wilson, 1986, The Journal of clinical investigation.

Structural changes induced by mupirocin in Staphylococcus aureus cells.

J. Wilson, A. Hann, M. Day, 1999, International journal of antimicrobial agents.

Mupirocin resistance in staphylococci: development and transfer of isoleucyl‐tRNA synthetase‐mediated resistance in vitro

J. Wilson, M. Day, A. Russell, 1999, Journal of applied microbiology.

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

J. Wilson, J. Engelhardt, B. Doranz, 1993, Human gene therapy.

Genetic mechanism(s) responsible for a deficiency of adenine phosphoribosyltransferase in man.

H. Simmonds, P. Daddona, J. Wilson, 1984, Advances in Experimental Medicine and Biology.

Hypoxanthine-guanine phosphoribosyltransferase. Genetic evidence for identical mutations in two partially deficient subjects.

B. Davidson, J. Wilson, T. Palella, 1988, The Journal of clinical investigation.

Human hypoxanthine-guanine phosphoribosyltransferase. Structural alteration in a dysfunctional enzyme variant (HPRTMunich) isolated from a patient with gout.

J. Wilson, W. Kelley, 1984, Journal of Biological Chemistry.

Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in a patient with the Lesch-Nyhan syndrome.

J. Wilson, W. Kelley, J. Wilson, 1983, The Journal of clinical investigation.

Human hypoxanthine (guanine) phosphoribosyltransferase: an amino acid substitution in a mutant form of the enzyme isolated from a patient with gout.

J. Wilson, G. Tarr, W. Kelley, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Human hypoxanthine-guanine phosphoribosyltransferase.

W N Kelley, J. Wilson, J M Wilson, 1983, The Journal of biological chemistry.

The primary structure and posttranslational modification of human hypoxanthine-guanine phosphoribosyltransferase.

J. Wilson, G. Tarr, W. Kelley, 1984, Advances in experimental medicine and biology.

Identification of the murine firefly luciferase-specific CD8 T-cell epitopes

J. Wilson, C. Bell, M. Limberis, 2009, Gene Therapy.

Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity.

James M. Wilson, J. Wilson, S. Raper, 1992, Human gene therapy.

Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors.

J. Wilson, K. Zimmer, M. Robinson, 2001, Human gene therapy.

Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.

J. Wilson, M. Zepeda, 1996, Gene Therapy.

Maintenance-dose prediction based on a single determination of concentration: dose of parent drug required to give a desired steady-state concentration of metabolite.

J. Wilson, J. Slattery, 1983, Journal of pharmaceutical sciences.

Epidermal growth factor and transforming growth factor-alpha mRNA in rat small intestine: in situ hybridization study.

J. Wilson, O. Koldovský, B. Dvořák, 1994, FEBS letters.

A recombinant adenoviral vector expressing a soluble form of VCAM-1 inhibits VCAM-1/VLA-4 adhesion in transduced synoviocytes.

B. Davidson, J. Wilson, B. Roessler, 1995, Gene therapy.

Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty.

G. Stassi, G. Condorelli, L. Fratta, 1999, Circulation research.

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

A. Levey, S. Kish, K. Shannak, 1996, Neurology.

The polyamine synthesis inhibitor alpha-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo.

P. Fletcher, S. Kish, J. Wilson, 1991, European journal of pharmacology.

Retroviral-mediated gene transfer in human hepatocytes.

J. Wilson, S. Raper, M. Grossman, 1992, Surgery.

Pharmacologically regulated gene expression in the retina following transduction with viral vectors

J. Bennett, J. Wilson, G. Gao, 2001, Gene Therapy.

A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus.

J. Wilson, G. Gao, R. Engdahl, 2000, Human gene therapy.

Making space for intestinal gene therapy.

J. Wilson, S. Raper, 1997, Gastroenterology.

Delivery and evaluation of recombinant adeno‐associated viral vectors in the equine distal extremity for the treatment of laminitis

J. Wilson, B. Gurda, D. Richardson, 2017, Equine veterinary journal.

Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.

B. Woda, J. Wilson, R. Fram, 1990, Cancer research.

Molecular mechanism(s) of deoxyribonucleoside toxicity in T-lymphoblasts.

B. Mitchell, J. Wilson, W. Kelley, 1979, Advances in experimental medicine and biology.

Long-term correction of genetic defect of liver function in rat by transplantation of liver cells after ultraviolet irradiation.

J. Wilson, N. Chowdhury, J. Chowdhury, 1989, Molecular biology & medicine.

Blastocyst euploidy and implantation rates in a young (<35 years) and old (≥35 years) presumed fertile and infertile patient population.

D. Griffin, J. Wilson, S. Gitlin, 2014, Fertility and sterility.

Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer.

J. Wilson, J M Wilson, K J Fisher, 1994, The Biochemical journal.

Vectors--shuttle vehicles for gene therapy.

J. Wilson, James M. Wilson, 1997, Clinical and experimental immunology.

Require Homeodomain Dna-binding Sites. Transcriptional Repression by Msx-1 Does Not

Hailan Zhang, J. Inostroza, J. Wilson, 1994 .

BAPS Prize--1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. British Association of Paediatric Surgeons.

K. Sylvester, J. Wilson, N. Adzick, 1999, Journal of Pediatric Surgery.

Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.

J. Olsen, M. Knowles, J. Wilson, 1994, Human Gene Therapy.